The Company is pleased to announce that the 5-ply version of its Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd (“Volz”), has been approved by the UK’s Medicines and
The Company is pleased to announce that the 5-ply version of its Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd (“Volz”), has been approved by the UK’s Medicines and
It is always an interesting sight to behold, the way a company morphs from one space to another. This is what we have been witnessing in recent months at the
Huge honour to support Ride4Rahma Challenging 70-mile ride from Dewsbury to the historic city of York to raise funds for ongoing projects in the Balkans registration charity, please donating here & share
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Part of the raison d’etre of #StockMarketWatch is to fill in the gaps left by the mainstream media.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Another fun-packed week with Supply@ME Capital (SYME.L) Q&A attracting a lot of attention and we have Alessandro Zamboni, CEO of Supply @ME on the Share Talk platform early next week.
New Pro-Larva mask incorporates unique British copper nanoparticle technology to create a virucidal barrier effective against Covid-19 and other viruses, including influenza
Part of the raison d’etre of #StockMarketWatch is to fill in the gaps left by the mainstream media.
The past couple of weeks have witnessed not so much a pullback in stocks, but a rather strange kind of undertow for bulls of small caps.
Finally, we got the opportunity to speak with Antony about today company update and ask a few questions we hope shareholders find informative. What is cleary stated, P2F’s company portfolio